MFN2 Influences Amyotrophic Lateral Sclerosis Pathology
Kristi L. Russell, Jonathan M. Downie, Summer B. Gibson, Karla Patricia Figueroa, Cody J. Steely, Mark B. Bromberg, Lewis Charles Murtaugh, Lynn B. Jorde, Stefan M. Pulst
The paper identifies MFN2 mutations in ALS patients and shows they impair mitochondrial function and increase TDP-43 levels in zebrafish models.
bioRxiv · Oct 30, 2021 · PreprintGenetics